HomeCASI • NASDAQ
add
CASI Pharmaceuticals Inc
Previous close
$1.76
Day range
$1.77 - $1.97
Year range
$1.64 - $7.67
Market cap
30.07M USD
Avg Volume
10.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 6.24M | 83.04% |
Operating expense | 13.85M | 25.63% |
Net income | -10.75M | -12.81% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.65M | -16.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.70M | -35.42% |
Total assets | 40.82M | -29.63% |
Total liabilities | — | — |
Total equity | -8.07M | — |
Shares outstanding | 5.49M | — |
Price to book | — | — |
Return on assets | -54.15% | — |
Return on capital | -148.67% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.75M | -12.81% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Headquarters
Website
Employees
233
